Non-opioid Pain Patches

Non-opioid Pain Patches Market Outlook

The global non-opioid pain patches market is projected to reach approximately USD 5.6 billion by 2035, growing at a CAGR of around 9.4% during the forecast period from 2025 to 2035. This growth is primarily driven by the increasing prevalence of chronic pain conditions, rising awareness regarding the side effects of opioid medications, and the growing demand for non-invasive pain management solutions. The shift towards non-opioid alternatives is being significantly influenced by regulatory bodies advocating for reduced opioid prescriptions, thus paving the way for non-opioid pain management products such as transdermal patches. Additionally, advancements in drug delivery technologies are enhancing the efficacy and user comfort of these patches, further propelling market growth.

Growth Factor of the Market

Several growth factors contribute to the expansion of the non-opioid pain patches market. First, the global rise in the aging population correlates with an increase in chronic pain conditions, such as arthritis and neuropathic pain, creating a substantial demand for effective pain management solutions. Second, the growing awareness about the adverse effects of opioids and their addiction potential is leading patients and healthcare providers to seek alternative pain relief methods. Third, the development of innovative formulations and technologies in non-opioid patches is improving drug delivery and patient adherence, making these therapies more appealing. Fourth, the rising healthcare expenditure and an increasing number of pain management clinics are creating more opportunities for the distribution of non-opioid patches. Finally, the impact of the COVID-19 pandemic has accelerated the shift towards telehealth and online pharmacies, allowing easy access to pain management products, further bolstering market growth.

Key Highlights of the Market

• The global non-opioid pain patches market is expected to reach USD 5.6 billion by 2035.
• A CAGR of approximately 9.4% is anticipated during the forecast period.
• Growing concerns over opioid addiction are driving demand for non-opioid alternatives.
• Innovative drug delivery systems are enhancing the effectiveness of pain patches.
• The increasing prevalence of chronic pain conditions contributes significantly to market expansion.

By Product Type

Lidocaine Patches:

Lidocaine patches have gained considerable popularity in the non-opioid pain patches market due to their effectiveness in providing localized pain relief. These patches work by administering a controlled dose of lidocaine, a local anesthetic, directly to the site of pain. They are particularly useful for patients suffering from conditions like postherpetic neuralgia and chronic pain syndromes. The convenience of a transdermal delivery system minimizes systemic exposure and potential side effects, making them a preferred option for both patients and healthcare professionals. The lidocaine patch market is anticipated to grow significantly as more healthcare providers recognize its benefits and as new formulations are developed to enhance efficacy and patient experience.

Capsaicin Patches:

Capsaicin patches are derived from chili peppers and are recognized for their unique mechanism of action in pain relief. These patches work by depleting substance P, a neuropeptide involved in pain signaling. This results in a gradual reduction in pain sensation. Capsaicin patches are particularly indicated for neuropathic pain and can be a valuable option for patients who have not responded well to conventional analgesics. The growing interest in natural and plant-based treatments is expected to foster the growth of the capsaicin patch segment within the non-opioid pain patches market. Additionally, ongoing research into the efficacy of high-concentration capsaicin patches may open new therapeutic applications in pain management.

NSAID Patches:

Nonsteroidal anti-inflammatory drug (NSAID) patches are another significant segment in the non-opioid pain patches market. These patches allow for the topical application of NSAIDs such as diclofenac, providing localized pain relief and reducing inflammation without the gastrointestinal side effects commonly associated with oral NSAIDs. The rise in musculoskeletal conditions, as well as an increasing preference for non-invasive treatment options, is propelling the demand for NSAID patches. With ongoing advancements in formulation technologies, NSAID patches are expected to become more effective, leading to wider acceptance among healthcare professionals and patients alike.

Salicylate Patches:

Salicylate patches, which typically contain methyl salicylate, are recognized for their analgesic and anti-inflammatory properties, making them suitable for various pain conditions such as muscle pain and arthritis. These patches provide a unique advantage as they can be applied directly to the painful area, ensuring targeted relief while minimizing systemic side effects. With the increasing prevalence of arthritis and muscle-related disorders, the salicylate patch segment is poised for notable growth. Research and development efforts focusing on enhancing the absorption rates and patient compliance further contribute to the attractiveness of this product category in the non-opioid pain patches market.

Others:

The "Others" category within the product type segment includes various innovative formulations and combinations of ingredients used in non-opioid pain patches. This may encompass patches that combine multiple active ingredients to enhance pain relief or those formulated for specific target populations, such as athletes or elderly patients. The diversification of product offerings in this segment is indicative of the growing demand for personalized treatment solutions in pain management. As manufacturers continue to innovate and address the varied needs of patients, the "Others" category is expected to experience significant growth, reflecting the overall trends towards tailored healthcare solutions.

By Application

Muscle Pain:

Muscle pain management is one of the largest application segments within the non-opioid pain patches market. Muscle injuries, strains, and chronic conditions like fibromyalgia are common issues that necessitate effective treatment solutions. Non-opioid pain patches such as NSAID and salicylate patches provide localized relief, which can significantly improve the quality of life for affected individuals. The rising trend of active lifestyles and fitness culture has also contributed to the increased incidence of muscle-related injuries, thereby driving demand for effective and safe pain relief options. This segment is expected to continue expanding as awareness about non-opioid therapies becomes more widespread among consumers and healthcare providers.

Arthritis:

Arthritis represents another critical application area for non-opioid pain patches. With the global prevalence of arthritis on the rise, particularly among the aging population, there is an increasing demand for effective pain management solutions. Non-opioid patches containing ingredients like lidocaine or NSAIDs can provide targeted relief, helping to alleviate joint pain and improve mobility for arthritis patients. The convenience of using patches over oral medications enhances patient compliance, as they can deliver consistent doses over time with minimal side effects. The growing focus on managing chronic conditions effectively is anticipated to bolster the arthritis application segment within the non-opioid pain patches market.

Neuropathic Pain:

Neuropathic pain, resulting from nerve damage or dysfunction, is a complex condition often challenging to treat. Non-opioid pain patches, particularly capsaicin and lidocaine patches, are increasingly being utilized to manage neuropathic pain due to their unique mechanisms of action. Capsaicin patches, for instance, work by reducing the levels of substance P, providing relief for conditions like diabetic neuropathy and postherpetic neuralgia. With the growing recognition of neuropathic pain as a significant health issue, the demand for specialized treatments, including non-opioid patches, is expected to rise, thereby enhancing this market segment.

Postoperative Pain:

Postoperative pain management is a crucial aspect of recovery after surgical procedures. Non-opioid pain patches offer a valuable alternative for managing pain without the risks associated with opioid medications. These patches can provide targeted relief at the surgical site and help minimize the need for oral analgesics, thereby reducing the overall burden of pain management. The rising trend of outpatient surgeries, where patients are discharged shortly after procedures, further emphasizes the need for effective and safe pain relief solutions like non-opioid patches. As more healthcare facilities adopt non-opioid strategies in postoperative care, this application segment is expected to experience robust growth.

Others:

The "Others" category in the application segment encompasses a variety of pain management scenarios that may not fall strictly into the previously mentioned categories. This may include pain associated with conditions such as fibromyalgia, sports injuries, or even cosmetic procedures. The versatility of non-opioid pain patches makes them suitable for several off-label uses, providing patients with effective relief options. As healthcare practitioners become more familiar with the benefits of non-opioid patches for diverse applications, this segment is expected to grow as well, reflecting the broader acceptance of these products in various pain management strategies.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics distribution channel represents a significant portion of the non-opioid pain patches market. These healthcare settings are pivotal for patient education and prescription of pain management solutions. Medical professionals in hospitals and clinics often recommend non-opioid patches for their patients as a safer alternative to opioids. The presence of specialized pain management clinics further emphasizes the importance of this distribution channel, as they provide tailored treatments for patients with chronic pain conditions. As the healthcare industry increasingly focuses on effective pain management and reducing opioid prescriptions, the market share of the hospitals and clinics segment is expected to grow steadily in the coming years.

Retail Pharmacies:

Retail pharmacies serve as a convenient source for consumers seeking non-opioid pain patches. The accessibility of these pharmacies allows patients to purchase pain management products without the need for a prescription, promoting self-management of pain conditions. The increasing awareness of non-opioid alternatives among consumers has led to a growing demand for these products in retail settings. Additionally, promotional activities and marketing campaigns by pharmacies enhance visibility and consumer education regarding the benefits of non-opioid pain patches. The retail pharmacies segment is anticipated to continue growing as more individuals seek over-the-counter pain relief options without the risks associated with opioids.

Online Stores:

The rise of e-commerce has significantly transformed the distribution landscape, with online stores emerging as a popular channel for purchasing non-opioid pain patches. Online shopping offers consumers the convenience of home delivery and often provides a wider selection of products compared to traditional retail outlets. This distribution channel has gained particular traction during and after the COVID-19 pandemic, as patients seek safe and contactless shopping options. Moreover, online platforms often facilitate price comparison and product reviews, which can motivate informed purchasing decisions. The continued expansion of online pharmacies and e-commerce platforms is expected to drive growth in this segment, contributing to the overall non-opioid pain patches market expansion.

Others:

The "Others" category encompasses various alternative distribution channels that may include health food stores, specialty shops, and direct selling by manufacturers. These channels provide additional access points for consumers looking for non-opioid pain relief options. Notably, direct sales from manufacturers often include specialized marketing strategies that target niche consumer segments seeking natural and alternative therapies. The diversification of distribution channels allows for broader reach and accessibility of non-opioid pain patches, ensuring that a variety of consumer preferences and needs are met. As the demand for these products continues to rise, the "Others" segment is likely to see consistent growth in conjunction with the overall market.

By Ingredient Type

Lidocaine:

Lidocaine is one of the most common active ingredients found in non-opioid pain patches, renowned for its local anesthetic properties. Patches containing lidocaine offer targeted pain relief by blocking nerve signals in the affected area, making them particularly effective for localized pain conditions such as postherpetic neuralgia and chronic pain syndromes. The growing acceptance of lidocaine patches by healthcare professionals and patients alike is driving their popularity within the non-opioid pain patches market. As research continues to explore new formulations and delivery mechanisms, the utilization of lidocaine patches is expected to expand further, catering to the increasing demand for safe and effective pain relief options.

Capsaicin:

Capsaicin, derived from chili peppers, is another significant ingredient used in non-opioid pain patches. Known for its unique ability to deplete substance P and disrupt pain signaling pathways, capsaicin patches are particularly beneficial in managing neuropathic pain and certain inflammatory conditions. The growing interest in natural and alternative therapies has led to an increased demand for capsaicin-containing patches, especially among patients looking for non-pharmaceutical pain management solutions. As manufacturers refine their formulations to enhance absorption and effectiveness, the capsaicin segment within the non-opioid pain patches market is expected to witness substantial growth.

Ibuprofen:

Ibuprofen patches represent a significant advancement in the delivery of this widely used NSAID. These patches provide localized pain relief while minimizing systemic exposure, making them a safer alternative to oral NSAIDs. The convenience of transdermal delivery enhances patient adherence and allows for consistent dosing over time. As the prevalence of musculoskeletal pain continues to rise, the demand for ibuprofen patches is expected to increase accordingly. Moreover, ongoing research into the effectiveness of ibuprofen in patch form will likely contribute to the growth of this ingredient type in the non-opioid pain patches market.

Methyl Salicylate:

Methyl salicylate is commonly used in topical analgesics and is also included in non-opioid pain patches due to its anti-inflammatory and analgesic properties. It is effective in relieving pain associated with conditions such as muscle strains, arthritis, and sports injuries. The ability of methyl salicylate patches to provide targeted relief makes them an attractive option for patients seeking non-invasive pain management solutions. The growing awareness of the benefits of topical analgesics is expected to drive the demand for methyl salicylate patches within the non-opioid pain patches market as more consumers and healthcare providers recognize their effectiveness.

Others:

The "Others" category within the ingredient type segment encompasses a range of innovative formulations and combinations of various active ingredients in non-opioid pain patches. This may include patches that combine lidocaine with other analgesics or natural extracts for enhanced efficacy. The increasing focus on personalized medicine and tailored treatment options is driving the development of unique formulations to address diverse pain conditions. As research and development efforts continue to explore new ingredient combinations and approaches, the "Others" segment is expected to grow as patients seek customized pain management solutions that suit their specific needs.

By Region

The regional analysis of the non-opioid pain patches market reveals significant variations in market dynamics across different parts of the world. In North America, the market is anticipated to experience substantial growth due to the high prevalence of chronic pain disorders and the growing awareness of the risks associated with opioid use. The region is projected to capture a significant share of the market, contributing approximately USD 2.2 billion by 2035, with a CAGR of around 10.2%. The increasing number of pain management clinics and the adoption of non-opioid therapies among healthcare providers will further support this growth trajectory in North America.

In Europe, the non-opioid pain patches market is expected to witness steady growth, driven by a rising geriatric population and increasing healthcare expenditure. The European market is projected to reach approximately USD 1.5 billion by 2035, with a CAGR of about 8.6%. Countries such as Germany, France, and the UK are leading the market due to their advanced healthcare infrastructure and growing emphasis on effective pain management strategies. Additionally, the increasing prevalence of arthritis and musculoskeletal disorders is expected to enhance the uptake of non-opioid pain patches across the region, aligning with the overall market growth trends.

Opportunities

The non-opioid pain patches market presents numerous opportunities for growth and innovation, particularly in addressing the changing needs of patients. One of the most significant opportunities lies in the continuous development of advanced formulations and delivery mechanisms. Manufacturers can explore the integration of new technologies, such as microneedles or nanotechnology, to enhance the absorption and efficacy of active ingredients in pain patches. Additionally, there is a growing demand for personalized pain management solutions, allowing companies to tailor their products to address specific pain conditions or demographics, further expanding the market reach. As the healthcare landscape shifts towards preventive and personalized care strategies, companies that focus on innovation and customization will likely gain a competitive edge.

Another promising opportunity can be found in expanding distribution channels to enhance accessibility and reach a broader audience. The rise of e-commerce and online pharmacies presents a unique avenue for growth, allowing manufacturers to provide direct-to-consumer options and capitalize on the trend toward online shopping. Additionally, partnerships with healthcare providers and pain management clinics can facilitate better patient education and awareness about non-opioid pain patches, thereby increasing their adoption. By fostering collaborations and maximizing distribution strategies, companies can significantly enhance their market presence and capture a larger share of the growing non-opioid pain patches market.

Threats

Despite the positive outlook for the non-opioid pain patches market, several threats could pose challenges to growth. One significant threat is the increasing competition from alternative pain management therapies, including emerging technologies such as virtual reality for pain management, acupuncture, and other non-invasive treatment modalities. As these alternatives gain traction, they may divert consumer interest away from traditional pain patches, impacting sales. Additionally, the market is susceptible to regulatory challenges and varying approval processes across different regions. Delayed or fluctuating regulatory approvals for new products may hinder manufacturers' ability to bring innovative solutions to market in a timely manner, limiting their competitive advantage.

Moreover, the potential for adverse reactions or ineffective treatment outcomes can undermine consumer confidence in non-opioid pain patches. Negative clinical trials or reports of side effects could result in decreased demand and increased scrutiny from regulatory bodies. Manufacturers must also contend with the challenge of educating consumers and healthcare providers about the benefits and proper usage of non-opioid pain patches, particularly in an environment where misinformation may spread rapidly. Addressing these threats requires proactive strategies, including robust clinical research, effective marketing campaigns, and continuous engagement with stakeholders to foster trust and credibility within the market.

Competitor Outlook

• Pfizer Inc.
• Haleon Plc
• Johnson & Johnson
• Grünenthal GmbH
• Galena Biopharma, Inc.
• Endo International plc
• Medtronic plc
• Novartis AG
• Hisamitsu Pharmaceutical Co., Inc.
• Reckitt Benckiser Group plc
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Hikma Pharmaceuticals PLC
• Actavis LLC
• GSK Consumer Healthcare

The competitive landscape of the non-opioid pain patches market is characterized by a mix of established pharmaceutical companies and emerging players focused on innovative solutions. Major companies such as Pfizer Inc. and Johnson & Johnson play a significant role in market dynamics, leveraging their extensive research and development capabilities to enhance their product offerings. These companies have diversified portfolios, including various types of pain management products, which allows them to capture a larger share of the market. Additionally, they benefit from strong brand recognition and established distribution networks, which provide a competitive advantage in reaching healthcare providers and consumers alike.

Emerging companies like Galena Biopharma and Grünenthal GmbH are also making significant strides in the non-opioid pain patches market by focusing on niche segments and innovative formulations. Their commitment to developing targeted therapies for specific pain conditions enables them to cater to a diverse patient population. As these companies invest in clinical trials and research, they can bring novel therapies to market, contributing to their competitive positioning. Moreover, strategic collaborations and partnerships with healthcare institutions can enhance their visibility and credibility, further amplifying their market presence.

Furthermore, companies are increasingly focusing on sustainability and environmentally-friendly practices in their product development strategies. This trend is becoming essential, as consumers and healthcare providers alike are leaning towards brands that prioritize eco-friendly initiatives. Companies like Hisamitsu Pharmaceutical and Reckitt Benckiser are integrating sustainable practices into their manufacturing processes, thus appealing to environmentally-conscious consumers. As the competitive landscape continues to evolve, companies that embrace innovation, sustainability, and consumer preferences are likely to thrive and capture a larger share of the non-opioid pain patches market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Haleon Plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Actavis LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novartis AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Pfizer Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Sanofi S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medtronic plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Endo International plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Galena Biopharma, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Grünenthal GmbH
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 GSK Consumer Healthcare
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hikma Pharmaceuticals PLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Reckitt Benckiser Group plc
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hisamitsu Pharmaceutical Co., Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Teva Pharmaceutical Industries Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Non-opioid Pain Patches Market, By Application
    • 6.1.1 Muscle Pain
    • 6.1.2 Arthritis
    • 6.1.3 Neuropathic Pain
    • 6.1.4 Postoperative Pain
    • 6.1.5 Others
  • 6.2 Non-opioid Pain Patches Market, By Product Type
    • 6.2.1 Lidocaine Patches
    • 6.2.2 Capsaicin Patches
    • 6.2.3 NSAID Patches
    • 6.2.4 Salicylate Patches
    • 6.2.5 Others
  • 6.3 Non-opioid Pain Patches Market, By Ingredient Type
    • 6.3.1 Lidocaine
    • 6.3.2 Capsaicin
    • 6.3.3 Ibuprofen
    • 6.3.4 Methyl Salicylate
    • 6.3.5 Others
  • 6.4 Non-opioid Pain Patches Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Stores
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Non-opioid Pain Patches Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Non-opioid Pain Patches market is categorized based on

By Product Type

• Lidocaine Patches
• Capsaicin Patches
• NSAID Patches
• Salicylate Patches
• Others

By Application

• Muscle Pain
• Arthritis
• Neuropathic Pain
• Postoperative Pain
• Others

By Distribution Channel

• Hospitals & Clinics
• Retail Pharmacies
• Online Stores
• Others

By Ingredient Type

• Lidocaine
• Capsaicin
• Ibuprofen
• Methyl Salicylate
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Pfizer Inc.
• Haleon Plc
• Johnson & Johnson
• Grünenthal GmbH
• Galena Biopharma, Inc.
• Endo International plc
• Medtronic plc
• Novartis AG
• Hisamitsu Pharmaceutical Co., Inc.
• Reckitt Benckiser Group plc
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Hikma Pharmaceuticals PLC
• Actavis LLC
• GSK Consumer Healthcare